The regulatory landscape for CBD is still developing. ​While Epidiolex is FDA-approved, other CBD ​products are not, leading to concerns about quality, ​dosage, and safety. There's a risk of mislabeling, ​where products might contain different amounts of ​CBD or even THC than advertised.